| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1013371387 |
| P356 | DOI | 10.1291/HYPRES.31.553 |
| P698 | PubMed publication ID | 18497476 |
| P5875 | ResearchGate publication ID | 5353759 |
| P2093 | author name string | Carlos M Ferrario | |
| Michiya Igase | |||
| Katsuhiko Kohara | |||
| Tetsuro Miki | |||
| Tokihisa Nagai | |||
| P433 | issue | 3 | |
| P304 | page(s) | 553-559 | |
| P577 | publication date | 2008-03-01 | |
| P1433 | published in | Hypertension Research | Q15762136 |
| P1476 | title | Increased expression of angiotensin converting enzyme 2 in conjunction with reduction of neointima by angiotensin II type 1 receptor blockade | |
| P478 | volume | 31 |
| Q99618979 | A Retrospective Study from 2 Centers in China on the Effects of Continued Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients with Hypertension and COVID-19 |
| Q45287587 | ACE2 activation confers endothelial protection and attenuates neointimal lesions in prevention of severe pulmonary arterial hypertension in rats |
| Q38567063 | ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension |
| Q37806553 | ACE2: more of Ang-(1-7) or less Ang II? |
| Q95295337 | ACEI/ARB Use and Risk of Infection or Severity or Mortality of COVID-19: A Systematic Review and Meta-analysis |
| Q55465043 | Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7). |
| Q33443452 | Angiotensin II reduces membranous angiotensin-converting enzyme 2 in pressurized human aortic endothelial cells |
| Q37155907 | Angiotensin-converting enzyme 2 in the brain: properties and future directions |
| Q37440125 | Angiotensin-converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid-β and tau pathology |
| Q100515537 | Anti-Inflammatory Drugs and the Renin-Angiotensin-Aldosterone System: Current Knowledge and Potential Effects on Early SARS-CoV-2 Infection |
| Q94503566 | Anti-RAS drugs and SARS-CoV-2 infection |
| Q98209622 | Commentary on "angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic" |
| Q37167510 | Effect of angiotensin receptor blockade on endothelial function: focus on olmesartan medoxomil |
| Q98774280 | Is Sex a Determinant of COVID-19 Infection? Truth or Myth? |
| Q37660786 | New physiological concepts of the renin-angiotensin system from the investigation of precursors and products of angiotensin I metabolism |
| Q39784603 | Olmesartan improves endothelial function in hypertensive patients: link with extracellular superoxide dismutase |
| Q46145696 | Olmesartan improves left ventricular function in pressure-overload hypertrophied rat heart by blocking angiotensin II receptor with synergic effects of upregulation of angiotensin converting enzyme 2. |
| Q37390013 | Olmesartan is More Effective Than Other Angiotensin Receptor Antagonists in Reducing Proteinuria in Patients With Chronic Kidney Disease Other Than Diabetic Nephropathy |
| Q43274970 | Olmesartan reduces oxidative stress in the brain of stroke-prone spontaneously hypertensive rats assessed by an in vivo ESR method |
| Q35726197 | Protective Role of the ACE2/Ang-(1-9) Axis in Cardiovascular Remodeling |
| Q55365578 | Reduced vasorin enhances angiotensin II signaling within the aging arterial wall. |
| Q55508970 | Telmisartan protects chronic intermittent hypoxic mice via modulating cardiac renin-angiotensin system activity. |
| Q24633556 | The ANG-(1-7)/ACE2/mas axis in the regulation of nephron function |
| Q50909853 | The components of the angiotensin-(1-7) system are differentially expressed during follicular wave in cattle. |
Search more.